Addictions: ce qui a changé en 2024

Yasser Khazaal; Maèva Flayelle; Joël Billieux; Louise Penzenstadler; Tiphaine Robet; Radu Iuga; Ansgar Rougemont-Bücking; Isabelle Gothuey; André Kuntz; Rafik Bouzegaou; Ghazaleh Soleimani; Hamed Ekhtiari; Germano Vera Cruz; Daniele Zullino

doi:10.53738/REVMED.2025.21.903.183

Addictions: ce qui a changé en 2024

Translated title of the contribution: Addiction: what's new in 2024

Yasser Khazaal
, Maèva Flayelle
, Joël Billieux
, Louise Penzenstadler
, Tiphaine Robet
, Radu Iuga
, Ansgar Rougemont-Bücking
, Isabelle Gothuey
, André Kuntz
, Rafik Bouzegaou
, Ghazaleh Soleimani
, Hamed Ekhtiari
, Germano Vera Cruz
, Daniele Zullino

Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Addiction medicine is confronting challenges brought about by changes in our modern world, including shifts in the drug market and the increasing digitalization of our environments. This article highlights some of these challenges and explores potential strategies to address them. The field is also advancing through robust research momentum in psychedelic-assisted psychotherapy. Additionally, the rapid growth of non-invasive brain stimulation techniques and artificial intelligence-driven research demonstrates the integration of cutting-edge technologies into addiction medicine, with the potential to transform clinical practice in the years ahead.

Translated title of the contribution	Addiction: what's new in 2024
Original language	French
Pages (from-to)	183-188
Number of pages	6
Journal	Revue Medicale Suisse
Volume	21
Issue number	903
DOIs	https://doi.org/10.53738/REVMED.2025.21.903.183
State	Published - Jan 29 2024

Bibliographical note

Publisher Copyright:
© 2024 Editions Medecine et Hygiene. All rights reserved.

Publisher link

10.53738/REVMED.2025.21.903.183

Find It

Find It at U of M Libraries

Cite this

@article{6564d81be89b4a04a66ecf0c61363287,

title = "Addictions: ce qui a chang{\'e} en 2024",

abstract = "Addiction medicine is confronting challenges brought about by changes in our modern world, including shifts in the drug market and the increasing digitalization of our environments. This article highlights some of these challenges and explores potential strategies to address them. The field is also advancing through robust research momentum in psychedelic-assisted psychotherapy. Additionally, the rapid growth of non-invasive brain stimulation techniques and artificial intelligence-driven research demonstrates the integration of cutting-edge technologies into addiction medicine, with the potential to transform clinical practice in the years ahead.",

author = "Yasser Khazaal and Ma{\`e}va Flayelle and Jo{\"e}l Billieux and Louise Penzenstadler and Tiphaine Robet and Radu Iuga and Ansgar Rougemont-B{\"u}cking and Isabelle Gothuey and Andr{\'e} Kuntz and Rafik Bouzegaou and Ghazaleh Soleimani and Hamed Ekhtiari and \{Vera Cruz\}, Germano and Daniele Zullino",

year = "2024",

month = jan,

day = "29",

doi = "10.53738/REVMED.2025.21.903.183",

language = "French",

volume = "21",

pages = "183--188",

journal = "Revue Medicale Suisse",

issn = "1660-9379",

publisher = "Editions Medecine et Hygiene",

number = "903",

}

TY - JOUR

T1 - Addictions

T2 - ce qui a changé en 2024

AU - Khazaal, Yasser

AU - Flayelle, Maèva

AU - Billieux, Joël

AU - Penzenstadler, Louise

AU - Robet, Tiphaine

AU - Iuga, Radu

AU - Rougemont-Bücking, Ansgar

AU - Gothuey, Isabelle

AU - Kuntz, André

AU - Bouzegaou, Rafik

AU - Soleimani, Ghazaleh

AU - Ekhtiari, Hamed

AU - Vera Cruz, Germano

AU - Zullino, Daniele

PY - 2024/1/29

Y1 - 2024/1/29

N2 - Addiction medicine is confronting challenges brought about by changes in our modern world, including shifts in the drug market and the increasing digitalization of our environments. This article highlights some of these challenges and explores potential strategies to address them. The field is also advancing through robust research momentum in psychedelic-assisted psychotherapy. Additionally, the rapid growth of non-invasive brain stimulation techniques and artificial intelligence-driven research demonstrates the integration of cutting-edge technologies into addiction medicine, with the potential to transform clinical practice in the years ahead.

AB - Addiction medicine is confronting challenges brought about by changes in our modern world, including shifts in the drug market and the increasing digitalization of our environments. This article highlights some of these challenges and explores potential strategies to address them. The field is also advancing through robust research momentum in psychedelic-assisted psychotherapy. Additionally, the rapid growth of non-invasive brain stimulation techniques and artificial intelligence-driven research demonstrates the integration of cutting-edge technologies into addiction medicine, with the potential to transform clinical practice in the years ahead.

UR - https://www.scopus.com/pages/publications/85216743206

UR - https://www.scopus.com/pages/publications/85216743206#tab=citedBy

U2 - 10.53738/REVMED.2025.21.903.183

DO - 10.53738/REVMED.2025.21.903.183

M3 - Article

C2 - 39881644

AN - SCOPUS:85216743206

SN - 1660-9379

VL - 21

SP - 183

EP - 188

JO - Revue Medicale Suisse

JF - Revue Medicale Suisse

IS - 903

ER -

Addictions: ce qui a changé en 2024

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

Cite this